Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Bon Health vs Claya

Bon Health
Graded #93

Higher grade

vs+8.600000000000009
Claya
Graded #267

Lower grade

The verdict

Bon Health takes it — 71.4/100 to 62.8/100.

Bon Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Bon Health is a physician-led GLP-1 weight-loss telehealth service offering compounded semaglutide and tirzepatide on transparent commitment tiers — from $170/mo on the annual plan up to $330 month-to-month…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueBon Health +16
58
42
Dose & formulationBon Health +2
77
75
Clinical oversightBon Health +3
85
82
Labs & monitoringBon Health +12
65
53
FulfillmentBon Health +21
88
67
Contract termsClaya +8
53
61
Bon Health · left barClaya · right bar

The numbers

MetricBon HealthClaya
WeighScore71.4/10062.8/100
GradeCC
Scorecard rank#93#267
Semaglutide$170/mo (annual plan, compounded)$299/mo (compounded)
Tirzepatide$170/mo (annual plan, compounded)$299/mo (compounded)
CoverageAll 50 statesCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyYes
Bon Health

Graded #93 · C

Strengths

  • Transparent commitment-tier pricing from $170/mo (annual) for compounded semaglutide and tirzepatide; $0 membership fee, cancel anytime
  • Physician-led: comprehensive medical review and physician-titrated dosing, not a 2-minute quiz
  • 24/7 physician support included free with your order; 1-3 day rapid dispatch
  • Licensed in all 50 states; uses 503A & 503B compounding pharmacies; brand-name Wegovy/Ozempic/Zepbound/Mounjaro also offered

Where it loses points

  • Best rates require a 6- or 12-month commitment ($170-195/mo); month-to-month is $330/mo
  • Doesn't name its specific compounding pharmacy
  • No legal entity name or LegitScript certification shown on the site
  • Compounded GLP-1s are not FDA-approved (the site discloses this)
Claya

Graded #267 · C

Strengths

  • Two named licensed clinicians (Habashy, NMD MS and Barber, MD PhD) — rare transparency for compounded GLP-1
  • Two named pharmacy partners with full addresses (RedRock, UT and Healthware, KY)
  • Both injectable and oral-tablet forms offered for semaglutide and tirzepatide
  • Weight-loss money-back guarantee published on the homepage
  • Free expedited shipping included in the monthly price

Where it loses points

  • States-served list not disclosed — you must check at checkout
  • LegitScript certification status not displayed
  • Corporate legal entity not disclosed on the site or privacy policy
  • Oral compounded tablets have weaker efficacy data than injectable semaglutide
  • Intro pricing is higher at refill ($299), erasing the first-month advantage

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard